Confirm toxoplasmosis infection in immunocompromised hosts as well as fetuses and newborns. May be used to confirm equivocal antibody testing.
Qualitative Polymerase Chain Reaction
New York DOH Approval Status
Lavender (EDTA), pink (K2EDTA) or serum separator tube. OR Amniotic fluid, CSF, ocular fluid or tissue.
Separate serum or plasma from cells. Transfer 1 mL serum, plasma, amniotic fluid, CSF or ocular fluid to a sterile container. (Min: 0.5 mL) OR Tissue: Transfer to a sterile container and freeze immediately.
Heparinized specimens, tissues in optimal cutting temperature compound.
Specimen source required.
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 3 months
All Others: Ambient: 8 hours; Refrigerated: 5 days; Frozen: 3 months
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|0050112||Toxoplasma gondii Source||31208-2|
|0055591||Toxoplasma gondii by PCR||29904-0|
- T gondi DNA detection
- T. gondii PCR
- Toxoplasma gondii, Molecular Detection, PCR